BlackRock’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
BlackRock's CGON Position: Q3 2026 in Review
BlackRock increased its CG Oncology (CGON) stake by 1.5% in Q3 2026, buying an estimated $6.69M and bringing the position to 6,347,335 shares worth $450M. The position accounts for 0.01% of the portfolio, ranked #1264.
BlackRock first reported a position in CGON in Q1 2024 and has held it in 11 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q3 2026.
- BlackRock held 6,347,335 shares of CG Oncology worth $450M as of Q3 2026.
- BlackRock bought 91,047 CG Oncology shares in Q3 2026, an estimated $6.69M.
- CG Oncology made up 0.01% of BlackRock's portfolio in Q3 2026, its #1264 holding.
- BlackRock first reported a position in CG Oncology in Q1 2024 and has held it in 11 quarters since.
- 233 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.
Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.